Guangzheng Eye Hospital Group Co., Ltd.
Simbol: 002524.SZ
SHZ
4.16
CNYTržna cena danes
211.9824
Razmerje P/E
0.0000
Razmerje PEG
2.12B
Kapaciteta MRK
- 0.00%
Donos DIV
Guangzheng Eye Hospital Group Co., Ltd. (002524-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 307.1 | 91.1 | 65.4 | 89.3 | |||||||||||||||||
balance-sheet.row.short-term-investments | -143.74 | 0 | -68 | 31 | |||||||||||||||||
balance-sheet.row.net-receivables | 782.74 | 190.2 | 143.5 | 192.1 | |||||||||||||||||
balance-sheet.row.inventory | 151.98 | 29.6 | 57.3 | 53.2 | |||||||||||||||||
balance-sheet.row.other-current-assets | 23.34 | 5.6 | 3.3 | 5.9 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1265.15 | 316.5 | 269.5 | 340.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2511.93 | 619.7 | 687.6 | 744.2 | |||||||||||||||||
balance-sheet.row.goodwill | 1511.56 | 377.3 | 378.5 | 517.2 | |||||||||||||||||
balance-sheet.row.intangible-assets | 159.62 | 40 | 37 | 55.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1671.19 | 417.2 | 415.5 | 572.8 | |||||||||||||||||
balance-sheet.row.long-term-investments | 181.47 | 0 | 94 | 7.2 | |||||||||||||||||
balance-sheet.row.tax-assets | 182.98 | 49.7 | 40.6 | 40.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 376.81 | 146.3 | 50.2 | 123.6 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 4924.38 | 1232.9 | 1288 | 1488.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.account-payables | 1052.98 | 261.3 | 275.5 | 262.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 1503.14 | 383.2 | 360.8 | 289 | |||||||||||||||||
balance-sheet.row.tax-payables | 63.8 | 16 | 10.9 | 15.2 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 2004.97 | 493.8 | 448.9 | 505.7 | |||||||||||||||||
Deferred Revenue Non Current | 13.05 | 0 | 0 | 30 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.33 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 29.31 | 7.7 | 107.5 | 10.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2047.9 | 507.6 | 468.6 | 507.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1693.54 | 417.3 | 448.4 | 475.7 | |||||||||||||||||
balance-sheet.row.total-liab | 5054.77 | 1263.5 | 1282.7 | 1487.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 2068.45 | 518 | 515.4 | 516.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | -1219.92 | -299.7 | -308.4 | -214.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 200.82 | 0 | 46.5 | 16.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.22 | 65 | 19.6 | 21.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1123.57 | 283.3 | 273.1 | 340.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 11.18 | 2.6 | 1.7 | 0.8 | |||||||||||||||||
balance-sheet.row.total-equity | 1134.75 | 285.9 | 274.8 | 341.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6189.53 | - | - | - | |||||||||||||||||
Total Investments | 75.6 | 19.1 | 26 | 38.2 | |||||||||||||||||
balance-sheet.row.total-debt | 3508.11 | 877 | 809.7 | 794.7 | |||||||||||||||||
balance-sheet.row.net-debt | 3201.01 | 785.9 | 744.3 | 736.4 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 18.29 | -77.8 | 36.4 | 32.1 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | -23.36 | 100 | 106.4 | 62.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | -3.08 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0.15 | 2.5 | 6 | 13.1 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -108.9 | 27.9 | 32.8 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 48.7 | -23.6 | 28.8 | ||||||||||||||||
cash-flows.row.inventory | 0 | -8.7 | 16.9 | -3.9 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -146.7 | 35.8 | 18.8 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 39.32 | 210.7 | -30.1 | 25.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 31.18 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.acquisitions-net | 25.73 | 1.8 | 83.9 | 194.5 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -25.73 | -116.4 | -262.1 | -543 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4.07 | 54.7 | 228.4 | 33.9 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.92 | 0 | 3.5 | 7.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -6.23 | -100.6 | 1.2 | -369.6 | ||||||||||||||||
cash-flows.row.debt-repayment | -170.2 | -232 | -467 | -130.7 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.1 | 22.7 | 29.5 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3.1 | -22.7 | -29.5 | ||||||||||||||||
cash-flows.row.dividends-paid | -15.3 | -11.9 | -16.5 | -46.6 | ||||||||||||||||
cash-flows.row.other-financing-activites | 68.2 | 232.2 | 273.7 | 255.3 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -53.06 | -11.8 | -209.8 | 78 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -3.24 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -29.13 | 12 | -63.2 | -136.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 255.13 | 57 | 45 | 108.3 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 284.26 | 45 | 108.3 | 244.8 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 31.18 | 124.3 | 145.4 | 155 | ||||||||||||||||
cash-flows.row.capital-expenditure | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.free-cash-flow | 9.46 | 83.6 | 92.9 | 92.9 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1058.07 | 1074.9 | 767.4 | 1044.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 689.43 | 697.9 | 575.9 | 709.2 | |||||||||||||||||
income-statement-row.row.gross-profit | 368.64 | 377 | 191.5 | 335.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 5.26 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 37.86 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 337.23 | 328.7 | 281.5 | 334.3 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1026.66 | 1026.6 | 857.4 | 1043.5 | |||||||||||||||||
income-statement-row.row.interest-income | 0.76 | 0.7 | 0.8 | 0.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 40.76 | 100.3 | 100 | 106.4 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 35.43 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -5.32 | 7 | 98.6 | 77 | |||||||||||||||||
income-statement-row.row.income-before-tax | -5.28 | 7.9 | -75.6 | 44.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -3.23 | -1.8 | 2.2 | 8.5 | |||||||||||||||||
income-statement-row.row.net-income | -1.62 | 9.3 | -77.8 | 36.9 |
Pogosto zastavljeno vprašanje
Kaj je Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) skupna sredstva?
Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) skupna sredstva so 1549365088.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 447607126.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.351.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.001.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.009.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.007.
Kaj je Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 9255045.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 877008780.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 328663038.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 65054312.000.